Meiotic recombination events are initiated by DNA double-strand breaks (DSBs) created by 20 the topoisomerase-like protein, Spo11. Similar to type-II topoisomerases, Spo11 becomes 21 covalently linked to the 5¢ ends generated on each side of the DSB. Whilst Spo11-oligos-the 22 product of nucleolytic removal by Mre11-have been detected in a number of biological 23 systems, the lifetime of the covalent Spo11-DSB precursor has not been systematically 24 determined and may be subject to alternative processing reactions. Here we explore the 25 activity of human Tyrosyl DNA Phosphodiesterase, TDP2, on Spo11-DSBs isolated from S. 26
product of nucleolytic removal by Mre11-have been detected in a number of biological 23 systems, the lifetime of the covalent Spo11-DSB precursor has not been systematically 24 determined and may be subject to alternative processing reactions. Here we explore the 25 activity of human Tyrosyl DNA Phosphodiesterase, TDP2, on Spo11-DSBs isolated from S. 26
cerevisiae cells. We demonstrate that TDP2 can remove Spo11 from natural ssDNA-oligos, 27
and dsDNA ends even when in the presence of excess competitor genomic DNA. 28
Interestingly, TDP2-processed Spo11-DSBs are refractory to resection by Exo1, suggesting 29 that ssDNA generated by Mre11 may be essential in vivo to facilitate resection-dependent HR 30 at Spo11-DSBs even if TDP2 were active. Moreover, although TDP2 can remove Spo11 31 peptides in vitro, TDP2 was unable to remove Spo11 in vivo-unlike during the repair of 32 topoisomerase-induced DNA lesions. These results suggest that Spo11-DNA, but not 33 topoisomerase-DNA cleavage complexes, are inaccessible to the TDP2 enzyme, perhaps due 34 to occlusion by higher order protein complexes resident at sites of meiotic recombination.
INTRODUCTION 32
In most organisms, meiotic recombination is essential to create genetically diverse, haploid 33 genomes suitable for sexual reproduction. In meiosis, homologous recombination (HR) 34 events are initiated by DNA double-strand breaks (DSBs) created by Spo11, a topoisomerase-35 like enzyme most closely related to the catalytic 'A' subunit of the archael type-IIB 36
Topoisomerase VI (1-3). TopoVI functions as an A 2 B 2 heterotetramer, and the recent 37 identification of the eukaryotic 'B' subunit, Top6BL, in mouse, plants and budding yeast 38
indicates that the active form of Spo11 is similarly heterotetrameric (4, 5). Like other type-II 39 and type-IIB topoisomerases, the Spo11 monomers become covalently attached via a 40 phosphotyrosine bond to the 5ʹ ends generated on each side of the DSB during cleavage (6-41 8). In wildtype S. cerevisiae cells, such covalent Spo11-DSBs are transient, being rapidly 42 processed by the nuclease activity of the MRX/N complex (Mre11, Rad50 and Xrs2/Nbs1), 43 which is stimulated by Sae2, the yeast orthologue of human CtIP (9-14). This coordinated 44 reaction generates a covalent single-stranded Spo11-oligonucleotide complex, flanked by a 45 nick or short ssDNA gap on the 5ʹ-ending strand that enables the DSB to be subsequently 46 channelled into homologous recombination repair via the onset of long-range ssDNA 47 resection catalysed by Exo1 (9, 15-17). Spo11-oligo complexes are formed in an 48 evolutionarily divergent yeast, Schizosaccharomyces pombe (18) , and are also detectable in 49 mouse spermatocytes (10, 19), suggesting that nucleolytic release is the default mode of 50 Spo11 removal in both unicellular and multicellular eukaryotes. 51 52 However, whilst the product of this nucleolytic reaction-Spo11-oligos-have been detected 53 in numerous biological systems, the lifetime of the covalent DSB precursor has not been 54 systematically determined and may be subject to alternative processing reactions. For 55 example, in S. pombe-and unlike in S. cerevisiae (2)-covalent Spo11-DSBs are readily 56 detected in wildtype cells (20) , indicating that DSB formation and the initiation of repair can 57 be temporally separated. Moreover, inactivation of the canonical Spo11 release reaction in C. 58 elegans (via mutation of COM-1, the CtIP/Sae2 orthologue) results in repair of DSBs by the 59 non-homologous endjoining (NHEJ) pathway and aberrant chromosome segregation (21, 22) . 60
These observations suggest that delayed onset of meiotic DSB resection may be especially 61 problematic for meiotic cells, and further suggest there must be a COM-1-independentmechanism to remove Spo11 in C. elegans, such that the DSBs can be ligated using the end-63 joining apparatus. Tyrosine phosphodiesterase 1 (Tdp1), which primarily resolves the 3ʹ covalent 74 phosphotyrosine links created by Top1 (24), and tyrosine phosphodiesterase 2 (TDP2, also 75 named TTRAP), which primarily resolves 5ʹ phosphotyrosine links created by Top2 (25). 76
Some enzymatic overlap between the activities and substrates of Tdp1 and TDP2 exists, 77 suggesting some functional redundancy in vivo (25, 26). Nevertheless, the primary activity of 78 Tdp1 activity aids the conversion of Top1 lesions into ligatable single-strand breaks (SSBs), 79 whereas TDP2 converts Top2 lesions into DSB ends suitable for direct repair by the NHEJ 80 pathway. The reaction product created by TDP2 contrasts with the 3ʹ single-stranded ends 81 generated as a result of MRX/N activity, and which are suitable for HR (9, 15, 27). 82
Interestingly, TDP2 is expressed in mouse and human testes tissue (28), leading to the 83 possibility that TDP2 may be able to process a subset of Spo11-DSB intermediates. 84
85
Here we use ectopic expression and in vitro biochemistry to explore the activity of human 86 TDP2 on Spo11-DSBs generated in S. cerevisiae meiotic cells. Collectively, our results 87 indicate that while TDP2 is catalytically capable of removing Spo11 from both Spo11-oligos 88 and Spo11-DSB ends in vitro, TDP2 is unable to do so in vivo. This is despite TDP2 89 functioning efficiently to suppress the sensitivity of mre11 or sae2 mutants to topoisomerase 90 poisons. These results suggest that Spo11-DSBs, but not Topoisomerase-DSBs, are 91 inaccessible to the TDP2 active site, perhaps due to occlusion by higher order protein 92 complexes resident at sites of meiotic recombination. Moreover, we find that the 2 nt 5ʹ 93 extensions revealed when Spo11 is removed from DSB ends by TDP2 in vitro are refractory 94 to nucleolytic resection by Exo1, suggesting that even were TDP2 to act during meiotic DSB 95 repair, it would nonetheless lead to DSBs being channelled away from the essential process 96 of homologous recombination. Overall, our findings provide insight into the mechanisms 97 involved in the resection and repair of protein-linked DSB ends created by topoisomerase-98 like enzymes such as Spo11, and how they may differ to the repair of 'clean'-ended DNA 99 breaks created by site-specific nucleases. 100
101

RESULTS
102
TDP2 removes Spo11 protein and peptides from single-stranded Spo11-oligo complexes. 103 To investigate whether Spo11-DSBs may also be a substrate for processing by TDP2-as are 112
Top2-induced DSBs (25)-we took advantage of the S. cerevisiae meiotic system in which 113 synchronised populations of cells undergo Spo11-DSB formation at hundreds of sites spread 114 across the genome (termed Spo11 hotspots), but in which TDP2 is not naturally expressed. 115
116
We first tested for the ability of recombinant TDP2 to remove Spo11 covalently attached to 117 ssDNA by enriching for the natural covalent Spo11-oligo complexes created by MRX and 118
Sae2-dependent processing of meiotic Spo11-DSBs in wildtype cells (Fig 1a) . Cells in mid 119 meiotic prophase (4 hours after meiotic entry) were harvested, lysed, and Spo11-oligo 120 complexes isolated by immunoprecipitation using antibodies raised against a C-terminal 121 triple FLAG epitope (30). 122
123
Immunoprecipitates were washed and then the ssDNA component labelled at the terminal 3ʹ 124 hydroxyl group using terminal deoxynucleotide transferase (TdT) and a radiolabelled 125 nucleotide (dCTP). Under the conditions employed, this reaction results in 1-4 radiolabelled 126 nucleotides being added to the 3ʹ OH end of the Spo11-oligo complex (D. Johnson and M. 127
Neale unpub. obs), which can be resolved via SDS-PAGE (Fig 1b) . Recombinant human 128 TDP2 (25) was reacted with these "full-length" labelled Spo11-oligo complexes, or with 129 complexes pre-treated with either trypsin or proteinase K (Fig 1c-f) . Based on substrate 130 specificity, trypsin is expected to leave twelve amino acid residues covalently attached to the 131 oligo complex via the phosphotyrosine bond, whereas proteinase K treatment will degrade all 132 but three amino acids in addition to the phosphotyrosine. 133
134
Following incubation with increasing concentrations of TDP2, reactions were halted by 135 adding formamide gel-loading buffer, then resolved on a 15% polyacrylamide gel under 136 DNA-denaturing conditions (Fig 1d-f) . Under these conditions, untreated Spo11-oligo 137 complexes fail to enter the gel and are often lost from the wells during gel handling and 138 fixation (Fig 1d) . By contrast, trypsin-treated molecules migrate as a heterogeneous smear, 139 presumably due to significant electrophoretic retardation caused by the remaining amino 140 acids bound to the DNA (Fig 1e) . Proteinase K treated samples migrate more uniformly, as a 141 pair of broad peaks, consistent with the previously characterised dual size classes of Spo11-142 oligo complex detected in S. cerevisiae (8-15 nt and 25-40 nt; Fig 1f; (9, 10) ). 143
144
Consistent with experiments performed using synthetic phosphotyrosine ssDNA substrates 145 (25) or partially proteolysed Top2-DNA covalent complexes (31), we observed robust 146 activity of TDP2 against both the partially and fully proteolysed Spo11-oligo substrates (Fig  147   1e,f) . In both cases, we observed the conversion of the radiolabelled signal to faster migrating 148 forms consistent with cleavage of the 5ʹ phosphotyrosine bond and complete removal of any 149 residual amino acids from the radiolabelled oligo. 150 151 Importantly, incubation of TDP2 with a radiolabelled oligononucleotide (i.e. without a 152 covalent protein attachment) resulted in no change in electrophoretic migration (Fig S1a) , 153 confirming that the increased rate of migration observed above (Fig 1e,f) was not due to trace 154 nuclease activity within the TDP2 preparation, but instead was due to the expected cleavage 155 of the protein-DNA phosphotyrosyl bond. 156
157
Structural modelling of TDP2 indicates that the catalytic site is buried within the core of the 158 protein, which any phosphotyrosine substrate would be required to thread into to be cleaved 159 (32-34). Intriguingly, however, we also observed conversion of non-migrating to rapidlymigrating oligo complexes when TDP2 was reacted with full-length Spo11-oligos, albeit only 161 restricted to the reactions containing the higher enzyme concentrations (Fig 1d) We next tested the ability of TDP2 to remove Spo11 from the naturally occurring double-169 stranded DNA (dsDNA) ends generated during meiosis. As introduced above, in wildtype S. 170 cerevisiae cells, Spo11-DSBs are normally rapidly processed by MRX/Sae2 (liberating 171 Spo11-oligo complexes) and then subjected to Exo1-dependent resection to create long 3ʹ 172 ending ssDNA tails. Thus, to enrich for a population of covalent Spo11-DSB molecules to 173 use as a substrate, and therefore to prevent such nucleolytic processing steps, we prepared 174 genomic DNA samples from sae2∆ cells in mid meiotic prophase (4 hours after meiotic 175 induction when DSBs are abundant). The resulting nucleic acid material is free from non-176 covalently attached protein contaminants but, due to the SAE2 gene deletion, retains covalent 177 Spo11-DSB intermediates (8, 35, 36). Samples were then incubated with and without TDP2 178 for up to 15 minutes, then subsequently reacted with lambda exonuclease-a 5ʹ-3ʹ 179 exonuclease with activity that depends on the presence of an unmodified 5ʹ phosphate group 180 on the substrate (37). Post-treatment with lambda exonuclease thus provides a sensitive test 181 for TDP2-dependent removal of the Spo11 moiety from the DSB end (Fig 2a) . 182
183
To monitor the reactions, DNA was digested with PstI, separated on an agarose gel, 184 transferred to nylon membrane and hybridised with a radiolabelled DNA probe that 185 recognises the HIS4::LEU2 meiotic recombination hotspot (38). Preparation in this way 186 reveals three distinct bands, the upper most is the parental DNA molecule, and the lower 187 smaller bands are indicative of DSBs arising at the two strong hotspots present at this 188 genomic locus (Fig 2b) . Treatment with lambda exonuclease alone resulted in no change in 189 the migration of the DSB bands-as expected due to the attached Spo11 protein preventing 190 5ʹ-3ʹ resection (Fig 2b) . By contrast, pretreatment with TDP2 led to complete disappearance 191 of the DSB bands-as expected if TDP2 was able to efficiently remove Spo11 from the DSB 192 end creating a clean 5ʹ phosphorylated substrate on which lambda exonuclease can act (Fig  193 2b) . Notably, the parental DNA band was stable under these conditions indicating that the 194 exonuclease degradation was specific to the deprotected Spo11-DSB ends (Fig 2b) . If we 195 assume there to be approximately 160 DSBs (39) within each replicated S. cerevisiae diploid 196 genome (~50 Mbp) there will be approximately one covalent Spo11-DSB end for every ~150 197 kb of genomic DNA. We conclude that recombinant TDP2 is able to efficiently remove 198
Spo11 from dsDNA ends even in the presence of a large excess of dsDNA. 199
200
Exo1 is unable to resect Spo11-DSBs that have been processed by TDP2. 201
As described above, the endogenous exonuclease involved in 5ʹ-3ʹ resection of Spo11-DSBs 202 is Exo1 (9, 15, 17). We were thus interested to examine whether treatment of Spo11-DSBs 203 with TDP2 could enable resection by recombinant Exo1, perhaps indicating a potential 204 mechanism to bypass the requirement of MRX/N nuclease activity in vivo. To perform these 205 experiments, we isolated genomic DNA from sae2∆ cells as described above, incubated with 206 and without TDP2 for up to 15 minutes, then incubated with recombinant Exo1 rather than 207 lambda exonuclease. Unlike treatment with lambda exonuclease, Exo1 was unable to initiate 208 resection on Spo11-DSBs whether or not they had been processed by TDP2 (Fig 3a,b) . 209
210
As a positive control to ensure that this inability to resect the Spo11-DSB end was not due to 211 a problem with our recombinant Exo1 preparation, we repeated the same set of assays with 212 genomic DNA isolated from an exo1∆ mutant (rather than sae2∆). Under these conditions, 213
MRX and Sae2-mediated nucleolytic cleavage of Spo11 from the DSB in vivo results in a 214 short 3ʹ ssDNA tail (up to ~300 bp) (15). As expected, incubation of this substrate with 215 recombinant Exo1 resulted in specific degradation of the DSBs whether or not they were first 216 treated with TDP2 (Fig 3c,d) . 217
218
As a final control, we confirmed that TDP2 was active in the Exo1 buffer by incubating the 219 Spo11-oligo substrate with TDP2 under the same conditions that the Exo1 resection assays 220 were performed (Fig S1b) . Collectively these results demonstrate that whilst TDP2 may have 221 the necessary biochemical activity to remove covalently attached Spo11 from DSB ends, the 222 resulting clean DNA ends are a poor substrate for Exo1 to initiate resection. 223 224 225
Exo1 is unable to resect Spo11-DSBs that have been blunted by Klenow fragment. 226
Spo11 creates a 2 nt 5ʹ overhang at the DSB ends (7, 39, 40). Prior in vitro assays using 227 relatively short (~3.0 kb) plasmid fragments indicated that the preferred substrate for Exo1 is 228 a dsDNA end with a 3ʹ extension, similar in form to the resected DSBs created by 229 MRX/Sae2, and in agreement with our observations presented above (41). By contrast, Exo1 230 displayed reduced, but not abolished, activity on substrates with a 4 nt 5ʹ extension, and only 231 moderately reduced activity on a blunt ended substrate (41). These latter findings contrast 232 somewhat with our observations that even just a 2 nt 5ʹ overhang completely prevents Exo1-233 catalysed resection of the TDP2-processed Spo11-DSBs (Fig 3a,b) . A possible explanation 234 for the difference may be the ratio of dsDNA to DSB ends, which is ~100-fold greater in our 235 assay system-and a much closer mimic of the conditions present in vivo during meiosis. 236 237 To determine whether Exo1 was able to resect blunt DSB ends under these same 'in vivo-238 like' conditions, we repeated the experiments utilising the TDP2-processed sae2∆ genomic 239 DNA, but this time including a preincubation step with Klenow fragment and dNTPs to blunt 240 the 2 nt 5ʹ overhang prior to incubation with Exo1 (Fig 3g,h) . Unlike for the partially resected 241 substrates, no resection by Exo1 was detectable even when DSB ends were first blunted by 242
Klenow fragment (Fig 3g,h ). Taken together our results suggest that Exo1 is acutely sensitive 243 to the structure of the DNA end, with partially resected ends-such as those created by 244 MRX/Sae2-dependent processing-being a significantly favoured substrate when excess 245 competitor dsDNA substrate is present. We suggest that our observations may represent a 246 closer match to the in vivo situation, where-even in meiosis-DSB ends are relatively 247 infrequent compared to the intact double-stranded genomic DNA. 248 249 Ectopic expression of TDP2 is unable to cleave Spo11 from DSB ends in S. cerevisiae. 250
An orthologue of the TDP2 protein is not present in S. cerevisiae. However, human TDP2 251 was identified via its ability to rescue the sensitivity of yeast cells to camptothecin (a Top1  252 poison), and to also suppress etoposide sensitivity (a Top2 poison) indicating that human 253 TDP2 is active when expressed in S. cerevisiae cells (25). Given our findings that TDP2 has 254 the appropriate biochemical activity to remove Spo11 from both ssDNA and dsDNA in vitro 255 (above), we were interested to investigate whether TDP2 expression during S. cerevisiae 256 meiosis would permit removal of Spo11 in vivo. 257
To test this idea, we placed His-tagged TDP2 under the control of the ADH1 promoter in a 259 sae2∆ strain, and induced cells to enter meiosis (Fig 4a) . Genomic DNA was harvested at 260 hourly intervals during meiotic prophase, and used to probe the DSB hotspot at the 261 HIS4::LEU2 locus as in earlier experiments (Fig 2 and Fig 3) . We observed no difference in 262 the abundance or electrophoretic mobility of the DSB bands in either the presence or absence 263 of TDP2 expression, indicating that TDP2 was neither promoting resection nor repair of the 264 Spo11-DSBs (Fig 4a) . Expression of TDP2 from an inducible GAL1 promoter construct after 265 4 hours in meiosis in a sae2∆ strain also resulted in no detectable alteration in DSB signal 266 (data not shown). 267 268 A possible explanation for no visible resection or repair of Spo11-DSBs after TDP2 269 expression is that TDP2 has removed Spo11 from the DSB end, but these DSBs, with 2 nt 5ʹ 270 overhangs, are resistant to nucleases such as Exo1 (as demonstrated in vitro in Fig 3) , and 271 that NHEJ components may be downregulated in meiosis perhaps due to increasing CDK 272 activity as has been observed in cycling S. pombe cells (42). To test this possibility, we 273 isolated genomic DNA from a 10 h meiotic time point from cells expressing TDP2, or from 274 control cells, and incubated with lambda exonuclease (Fig 4b) . At this time point, if TDP2 275 was capable of removing Spo11 from the 5ʹ end of the DSBs, lambda exonuclease would be 276 able to resect these DSBs (as described in Fig 2) . However, we detected no visible resection 277 in the TDP2-expressing nor control cells (Fig 4b) . These results suggest that despite the 278 ability of TDP2 to suppress topoisomerase-induced DNA damage in S. cerevisiae (25), 279 and etoposide sensitivity, as well as to the DNA-alkylating agent methyl methanesulphonate 286 as a control (MMS). At the concentrations tested, wild type control cells (pdr1∆) were not 287 sensitive to etoposide or camptothecin, and there was no effect of TDP2 expression (Fig 4c) . 288 sae2∆ cells were sensitive to the higher concentration of etoposide and CPT, and were 289 rescued efficiently by ectopic TDP2 expression (Fig 4c) . By contrast, whilst loss of Mre11 290 nuclease activity (mre11-H125N) resulted in drug sensitivities that were similar to the sae2∆ 291 mutant, TDP2 expression caused much weaker suppression than in the sae2∆ cells-292 particularly following CPT treatment (Fig 4c) . These observations suggest a separable role 293 for Sae2 and Mre11 in the repair of Top1-and Top2-induced DNA lesions, with TDP2 only 294 able to fully complement the functions of the Sae2 protein. Cells bearing a full deletion of 295 MRE11 were highly sensitive to even the lower drug concentrations, with no rescue of 296 growth observed upon expression of TDP2 (Fig 4c) . This latter result is consistent with the 297 inability for TDP2 to complement some or all of the many functions of Mre11 (44 Covalently bound protein at DNA ends has to be removed in order for repair to occur. Mre11 509 and Sae2 remove the protein block (Spo11 or topoisomerases) nucleolytically, generating a 3ʹ 510 ssDNA overhang substrate that is refractory to NHEJ, but the preferred substrate for long-511 range resection by Exo1, thereby promoting homologous recombination (left and right 512 panels). Removal of covalently bound protein, for example, by hydrolytically cleaving the 513 phosphotyrosyl bond between the protein and the 5ʹ end of the DSB (e.g. by TDP2) generates 514 clean, short 5ʹ overhang ends that are refractory to resection by Exo1-thus potentially 515 inhibiting repair by HR-but the complementary nature of the two ends may promote repair 516 by NHEJ, for example at Top2-DSBs (central panel). The inability for ectopic expression of 517 TDP2 to suppress the requirement for Sae2 in S. cerevisiae meiosis suggests that Spo11-518 DSBs, unlike Topoisomerase-DNA breaks, are inaccessible to TDP2, perhaps due to a large 519 complex at the Spo11-DSB site occluding access to TDP2 (dotted circle in left panel). 520 521 Figure 4: Ectopic expression of TDP2 cannot remove Spo11 from DSB ends in vivo, but can suppress camptothecin and etoposide sensitivity. a-b, Genomic DNA was isolated at the indicated timepoints from a synchronous meiotic culture of sae2∆ cells harbouring either an empty vector, or one expressing TDP2 from the ADH1 promoter (P ADH1 TDP2). DNA was purified and digested with PstI, separated by electrophoresis on a 0.7% agarose gel, blotted to nylon membrane and hybridised with a probe (MXR2 locus) close to the HIS4::LEU2 meiotic recombination hotspot. The location of the two major Spo11-DSBs at this locus are marked with solid arrowheads. In sae2∆ cells, Spo11 is not removed and resection cannot occur, causing DSB species to migrate as a tight band. Expression of TDP2 does not alter this migration pattern (a). b, DNA from the 10 h timepoints was incubated with lambda exonuclease for the indicated length of time. c, The indicated strains harbouring either an empty vector, or one expressing TDP2 from the ADH1 promoter (P ADH1 TDP2) were grown to log phase, serial diluted (10-fold), and spotted onto plates containing 300 µg/ml hygromycin (HYG), to maintain plasmid selection, and the indicated concentrations of etoposide, camptothecin (CPT) or methyl methanesulphonate (MMS), and incubated for 3 days at 30˚C. Covalently bound protein at DNA ends has to be removed in order for repair to occur. Mre11 and Sae2 remove the protein block (Spo11 or topoisomerases) nucleolytically, generating a 3ʹ ssDNA overhang substrate that is refractory to NHEJ, but the preferred substrate for long-range resection by Exo1, thereby promoting homologous recombination (left and right panels). Removal of covalently bound protein, for example, by hydrolytically cleaving the phosphotyrosyl bond between the protein and the 5ʹ end of the DSB (e.g. by TDP2) generates clean, short 5ʹ overhang ends that are refractory to resection by Exo1-thus potentially inhibiting repair by HR-but the complementary nature of the two ends may promote repair by NHEJ, for example at Top2-DSBs (central panel). The inability for ectopic expression of TDP2 to suppress the requirement for Sae2 in S. cerevisiae meiosis suggests that Spo11-DSBs, unlike Topoisomerase-DNA breaks, are inaccessible to TDP2, perhaps due to a large complex at the Spo11-DSB site occluding access to TDP2 (dotted circle in left panel). Figure S1 : Recombinant TDP2 is free of nuclease activity, and is active in the preferred Exo1 reaction buffer. a, To test for trace nuclease activity within the recombinant TDP2 preparation, a 30 nt oligonucleotide of random sequence was 3ʹ-labelled using TdT and radiolabelled dCTP then incubated with the stated concentrations of TDP2 at 37 °C for 1 hour then separated by denaturing urea-PAGE (19% acrylamide). The 30 nt oligo is indicated with a filled arrowhead. b, Proteinase Ktreated 3ʹ-labelled Spo11-oligo complexes as in Fig 1f were incubated with the indicated concentration of TDP2 at 37˚C for 1 hour in Exo1 reaction buffer (25 mM Tris acetate, pH 7.5, 1 mM DTT, 5 mM magnesium acetate, 100 mM sodium acetate, 0.25 mg/mL BSA) then separated by denaturing urea-PAGE (19% acrylamide). Solid arrowheads indicate the migration position of Spo11-oligo species (prior to TDP2 treatment). Open triangles indicate the migration position of Spo11-oligos after Spo11-peptide removal by TDP2. 
